Jupiter Life Line Hospitals Limited carries a market capitalization of 95.73B, placing it among publicly traded companies globally. Its enterprise value stands at 88.46B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 95.73B |
| Enterprise Value | 88.46B |
Jupiter Life Line Hospitals Limited currently has 65.57M shares outstanding.
| Shares Outstanding | 65.57M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Jupiter Life Line Hospitals Limited trades at a trailing price-to-earnings ratio of 45.26. The price-to-sales ratio is 5.89, and the price-to-book ratio stands at 11.00.
| PE Ratio | 45.26 |
| PS Ratio | 5.89 |
| PB Ratio | 11.00 |
| P/TBV Ratio | 5.73 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Jupiter Life Line Hospitals Limited trades at an EV/EBITDA multiple of 34.64 and an EV/FCF ratio of 363.21. The EV/Sales ratio of 5.92 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 34.64 provides insight into valuation relative to core operating earnings.
| EV / Sales | 5.92 |
| EV / EBITDA | 34.64 |
| EV / EBIT | 34.64 |
| EV / FCF | 363.21 |
Jupiter Life Line Hospitals Limited maintains a current ratio of 3.02, meaning it holds 3.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 37.84, indicating elevated leverage, while an interest coverage ratio of 7.82 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 3.02 |
| Quick Ratio | 2.39 |
| Debt / Equity | 37.84 |
| Debt / EBITDA | 2.29 |
| Interest Coverage | 7.82 |
Jupiter Life Line Hospitals Limited posts a return on equity of 27.16 and a return on invested capital of 9.82.
| Return on Equity (ROE) | 27.16 |
| Return on Assets (ROA) | 9.01 |
| Return on Invested Capital (ROIC) | 9.82 |
| Return on Capital Employed (ROCE) | 18.16 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 8.79 |
Over the trailing twelve months, Jupiter Life Line Hospitals Limited has paid 661.03M in income taxes, reflecting an effective tax rate of 25.40.
| Income Tax | 661.03M |
| Effective Tax Rate | 25.40 |
Jupiter Life Line Hospitals Limited's stock has declined approximately -4.60604% over the past 52 weeks. The 50-day moving average sits at 1,321.43, while the 200-day moving average is 1,362.28.
| Beta (5Y) | N/A |
| 52-Week Price Change | -4.60604% |
| 50-Day Moving Average | 1,321.43 |
| 200-Day Moving Average | 1,362.28 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Jupiter Life Line Hospitals Limited generated 14.94B in revenue and converted that into 1.94B in net income, yielding earnings per share of 28.26. EBITDA reached 2.55B, while operating income came in at 2.55B.
| Revenue | 14.94B |
| Gross Profit | 12.10B |
| Operating Income | 2.55B |
| Pretax Income | 2.60B |
| Net Income | 1.94B |
| EBITDA | 2.55B |
| EBIT | 2.55B |
| Earnings Per Share (EPS) | 28.26 |
Jupiter Life Line Hospitals Limited holds 5.40B in cash and equivalents against 5.84B in total debt, resulting in a net debt position of 4.54B. Total book value stands at 8.00B, with working capital of 4.58B providing operational flexibility.
| Cash & Cash Equivalents | 5.40B |
| Total Debt | 5.84B |
| Net Debt | 4.54B |
| Equity (Book Value) | 8.00B |
| Book Value Per Share | 116.51 |
| Working Capital | 4.58B |
Jupiter Life Line Hospitals Limited operates with a gross margin of 80.94, reflecting its pricing power and cost economics. The operating margin of 17.09 and net profit margin of 13.01 provide insight into operational efficiency.
| Gross Margin | 80.94 |
| Operating Margin | 17.09 |
| Pretax Margin | 17.41 |
| Profit Margin | 13.01 |
| EBITDA Margin | 17.09 |
Jupiter Life Line Hospitals Limited posts an Altman Z-Score of 7.94, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 7.94 |